Navigation Links
New Pain Management Clinic Opens In Traverse City
Date:8/7/2014

Traverse City, Michigan (PRWEB) August 07, 2014

A leading medical marijuana expert and Dr. Marla Gendelman are opening pain management clinics throughout Michigan, including a flagship office in Traverse City, and will focus on non-narcotic therapies that assist people with debilitating medical conditions and chronic illness, the company announced today.

"Liberate420 is devoted to improving quality-of-life for patients suffering from pain," said Daniel J. Reid, Liberate420's founder and chief executive. "All too often, pain management consists solely of prescribed narcotics, which often are not effective. Liberate420 was established to provide patients with alternative, more effective options, including medical marijuana therapy."

Reid co-founded the first medical marijuana business in Illinois under that state's new Compassionate Use of Medical Cannabis Pilot Program Act, which passed in 2013 and went into effect earlier this year. He also formerly headed a national medical marijuana patient advocacy group and earlier held top management positions with global firms in marketing and public affairs.

Dr. Marla Gendelman, a native of Michigan, is returning to her home state from Pittsburgh as Medical Director of Liberate420. She is a board certified anesthesiologist and a graduate of the University of Michigan School of Medicine. Over the past 25 years, Dr. Gendelman has been associated with the University of Pittsburgh Medical Center and also has held teaching positions there and at Drexel University.

Expansion Planned Throughout Michigan, Other States

Reid says Liberate 420 has established another office in Norton Shores to serve West Michigan and has plans for additional facilities in other markets in Michigan.“Part of our commitment to serving people in West Michigan is ease-of-access. People with serious illness, chronic pain and debilitating medical conditions don’t need the additional burden of having to travel long distances to see a doctor,” he says. “We are working to open in Grand Rapids, Lansing, Kalamazoo and other markets in the coming months.”

Liberate420 is also in negotiations to open offices in both Florida and Illinois. “We anticipate that Florida voters will approve Proposition 2 in the November election, which will make medical marijuana available in that state,” Reid says. “In Illinois, the medical marijuana law is in its infancy, and we plan to assist patients there in treating debilitating medical conditions as defined in the new Illinois law.”

About Liberate420

Liberate420 is a medical marijuana and pain management clinic that works with patients suffering from debilitating medical conditions and provides physician services to assist patients in improving quality of life. The company is based in Norton Shores (Muskegon) and is led by Daniel J. Reid and Dr. Marla Gendelman. Additional information about LIberate420 can be found at Liberate420.com

Read the full story at http://www.prweb.com/releases/2014/08/prweb12074266.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. In children born with severe heart defect, surgical management has little effect on neuro outcomes
2. Moffitt researcher publishes book on nutritional management of cancer treatment effects
3. Study finds overmanagement of benign breast disease
4. New biospecimens management system in development
5. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
6. Rutgers leads effort to replicate care management programs in 4 U.S. cities
7. NOVAtime Solutions to be showcased at Booth #1821 in the upcoming Society for Human Resource Management (SHRM) Annual Conference and Exposition
8. Funding for teacher classroom management study
9. Does Stress Management Slow MS?
10. Largest review of management and treatment of Barretts dysplasia and adenocarcinoma
11. Journal of Public Health Management and Practice now available on the iPad
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: